Yamaguchi Mizuki, Takakura Sho, Enomoto Naosuke, Teishikata Yasuhiro, Kitamura Asa, Maki Shintaro, Tanaka Kayo, Maezawa Tadashi, Tanaka Hiroaki, Ikeda Tomoaki
Department of Obstetrics and Gynecology, Mie University School of Medicine, Mie, Japan.
J Obstet Gynaecol Res. 2021 Dec;47(12):4256-4262. doi: 10.1111/jog.15036. Epub 2021 Sep 20.
This study aimed to compare the efficacy and safety of a controlled-release dinoprostone vaginal delivery system (PROPESS) and a metreurynter for labor induction.
This retrospective case-controlled study included 117 pregnant women (51 and 66 in the PROPESS and metreurynter groups, respectively) who required labor induction after >37 weeks' gestation at Mie University Hospital between January 2018 and September 2020. The primary outcome was the success rate of vaginal delivery. The secondary outcomes were changes in the Bishop score from the first insertion of PROPESS or the metreurynter to removal, uterine hyperstimulation and non-reassuring fetal status during the first insertion, proportion of pregnant women who needed pre-delivery oxytocin after removal, time to vaginal delivery after the first insertion, proportion of pregnant women who delivered vaginally within 12 or 24 h after the first insertion, and neonatal outcomes.
The proportion of pregnant women, especially primiparas, who delivered vaginally was significantly higher in the PROPESS group (26/34 [76.5%]) than in the metreurynter group (25/52 [48.1%]; p = 0.01). Moreover, among multiparas in the PROPESS group who delivered vaginally, nine (56.3%) out of 16 women delivered vaginally within 3 h of labor onset.
PROPESS for cervical ripening may reduce the risk of undergoing cesarean section in pregnant women requiring labor induction, especially primiparas. It is important to consider the possibility of precipitate labor when using the PROPESS in multiparas.
本研究旨在比较控释地诺前列酮阴道给药系统(普贝生)和子宫颈扩张球囊用于引产的有效性和安全性。
这项回顾性病例对照研究纳入了117例孕妇(普贝生组和子宫颈扩张球囊组分别为51例和66例),这些孕妇于2018年1月至2020年9月在三重大学医院妊娠超过37周后需要引产。主要结局是阴道分娩成功率。次要结局包括从首次放置普贝生或子宫颈扩张球囊到取出期间Bishop评分的变化、首次放置时子宫过度刺激和胎儿状况不良、取出后需要产前使用缩宫素的孕妇比例、首次放置后至阴道分娩的时间、首次放置后12或24小时内阴道分娩的孕妇比例以及新生儿结局。
普贝生组阴道分娩的孕妇比例,尤其是初产妇,显著高于子宫颈扩张球囊组(26/34 [76.5%] 对比25/52 [48.1%];p = 0.01)。此外,在普贝生组经阴道分娩的经产妇中,16名女性中有9名(56.3%)在分娩开始后3小时内阴道分娩。
普贝生用于促宫颈成熟可能会降低需要引产的孕妇,尤其是初产妇剖宫产的风险。在经产妇中使用普贝生时,考虑急产的可能性很重要。